Partial year: Data through Q3 2025 (Sept 30). Full-year totals not yet available.
HG

Hu Ge

JC Jiangsu Hengrui Medicine Co.: 6 patents #2 of 53Top 4%
SC Shanghai Hengrui Pharmaceutical Co.: 6 patents #2 of 36Top 6%
Overall (2025): #9,716 of 469,880Top 3%
8
Patents 2025

Issued Patents 2025

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12428482 Anti-PD-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof Xiaoling Gu, Xin Ye, Weikang Tao 2025-09-30
12428478 Anti-Claudin 18.2 antibody and application thereof Yang Yang, Weikang Tao 2025-09-30
12421286 Il-2 mutant and application thereof Yingying HU, Zhuoxiao CAO, Renhong TANG, Yayuan FU, Jinsheng REN 2025-09-23
12404323 Antibody capable of binding to thymic stromal lymphopoietin and use thereof Jinping Shi, Hua Ying, Tingting Li, Yifang Wang, Guimei Yang +1 more 2025-09-02
12319725 IL-2 mutant and application thereof Yingying HU, Zhuoxiao CAO, Renhong TANG, Yayuan FU, Jinsheng REN 2025-06-03
12258394 IL-5 antibody, antigen binding fragment thereof, and medical application therefor Hua Ying, Jinping Shi, Yifang Wang, Qiyue Hu, Weikang Tao 2025-03-25
12258405 CD3 antibody and pharmaceutical use thereof Hua Ying, Ling Zhang, Xiaoying Yang, Weikang Tao 2025-03-25
12202891 Antibody capable of binding to thymic stromal lymphopoietin and use thereof Jinping Shi, Hua Ying, Tingting Li, Yifang Wang, Guimei Yang +1 more 2025-01-21